Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.
Journal: Journal of gynecologic oncology
Published: September 22, 2023
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Journal: The New England journal of medicine
Published: January 19, 2022
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
Journal: Nature medicine
Published: August 09, 2018
The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.
Journal: British journal of haematology
Published: December 16, 2016
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.
Journal: Nature
Published: June 14, 2016
Approach to patients with primary refractory acute myeloid leukemia.
Journal: Current opinion in hematology
Published: January 10, 2015
Showing 1-6 of 6
Last Updated: 09/26/2026